Ocumension Therapeutics (5DG)
Market Closed
11 Aug, 20:00
XFRA 
€
0. 57
+0.01
+1.7857%
€
740.42M Market Cap
- P/E Ratio
- Div Yield
42 Volume
- Eps
€ 0.56
Previous Close Want to track 5DG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ocumension Therapeutics (5DG) Statistics
Valuation metrics
Market Cap 740.42M
Enterprise value 64.71M
Trailing P/E (ttm) -2.36
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.92
Price/Book (mrq) 1.61
Enterprise Value/Revenue 0.65
Enterprise Value/EBITDA -6.26
Overview
Shares outstanding 803.28M
Float 291.03M
Shares short -
% Held by insiders 0.49%
% Held by institutions 0.18%
Average volume (10 days) 29
Average volume (90 days) 27
Price summary
52-Week low 0.43
52-Week high 1.35
Beta 0.48
50-Day moving average 0.78
200-Day moving average 0.89
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -0.2%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.04%
Income Statement
Revenue (ttm) 100.08M
Revenue per share (ttm) 1.01
Quarterly revenue growth (yoy) 1.04%
Gross profit (ttm) 44.91M
EBITDA -10.34M
Net income to common (ttm) -19.76M
Diluted EPS (ttm) -0.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 50.07M
Total cash per share (mrq) 0.5
Total debt (mrq) 23.33M
Total Debt/Equity (mrq) 5.09
Current ratio (mrq) 3.7%
Book value per share (mrq) 0.57
Cash Flow
Cash flow statement -253.34M
Levered free cash flow (LFCF) -268.27M
